Aktiesnakken — November 2009
-
altså at belåningsværdien ændres i genmab?
-
-
det er jo principielt en grotesk melding.... der er jo likviditet i stride strømme i aktien
-
og det må være det altoverskyggende argument når man beregner belåningsværdi...
-
medmindre der er en vind/forsving nyhed lige om hjørnet
-
exactly stengård + de kan ikke garantere at de ikke sælger anyway
-
Flush out Friday the 13th
-
der bliver købt massivt op
-
GEN: passer meget godt: http://npinvestor.dk/nyheder/sydbank-genmabs-kursfald-en-overreaktion-196125.aspx
-
kun nordea i top 5
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind